Covid-19 is surging yet again. Is your lab ready for the demand?
According to the CDC, the current weekly average of new COVID-19 cases has increased by 49.6% with a reported total of 99,241,649 COVID-19 cases in the United States as of December 7, 2022. Covid-19-related hospitalizations have increased by roughly 25% in the last two weeks. With influenza and respiratory-related illnesses on the rise as well, healthcare providers are relying on PCR testing to provide an accurate diagnosis to assist in targeting the most effective treatment plan for patients. Many reliable sources are projecting to continue to see a rise in COVID-19 and Influenza in the United States. DTPM offers the following accurate molecular testing assays and panels that are readily available to laboratories and healthcare providers.
- FDA EUA Authorized DTPM COVID-19 RT-PCR Test
- COVID-19 and *Flu Molecular Testing Panel
- *Respiratory Molecular Testing Panel RPP
As well as supplying reliable and accurate molecular assays/panels, DTPM also provides laboratory setup, equipment, analyzer service, reagents, and consumables to reference laboratories and healthcare facilities. We deliver complete program management for molecular testing and more.
*For Research Use Only. Not for use In diagnostic procedures.
[flat_button text=”Visit Our Store” title=”Visit the DTPM store” url=”https://store.dtpm.com” padding=”10px 20px” bg_color=”#2a7bf2″ border_color=”#2A7BF2″ border_width=”1px” text_color=”#ffffff” text_size=”1.2rem” align=”left” target=”_blank”] [flat_button text=”Call Sales at 256-845-1261″ title=”Call Sales at 256-845-1261″ url=”tel:+2568451261″ padding=”10px 20px” bg_color=”#DE731D” border_color=”#DE731D” border_width=”1px” text_color=”#ffffff” text_size=”1.2rem” align=”left” target=”_blank”]